Growth Metrics

Oncology Institute (TOI) Receivables - Other (2020 - 2025)

Oncology Institute's Receivables - Other history spans 6 years, with the latest figure at $322000.0 for Q4 2025.

  • For Q4 2025, Receivables - Other fell 6.94% year-over-year to $322000.0; the TTM value through Dec 2025 reached $322000.0, down 6.94%, while the annual FY2025 figure was $322000.0, 6.94% down from the prior year.
  • Receivables - Other reached $322000.0 in Q4 2025 per TOI's latest filing, down from $339000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.3 million in Q1 2022 to a low of $276000.0 in Q2 2025.
  • Average Receivables - Other over 5 years is $515352.9, with a median of $422000.0 recorded in 2022.
  • Peak YoY movement for Receivables - Other: skyrocketed 994.69% in 2021, then plummeted 66.54% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $1.2 million in 2021, then crashed by 50.12% to $617000.0 in 2022, then dropped by 10.7% to $551000.0 in 2023, then tumbled by 37.21% to $346000.0 in 2024, then dropped by 6.94% to $322000.0 in 2025.
  • Per Business Quant, the three most recent readings for TOI's Receivables - Other are $322000.0 (Q4 2025), $339000.0 (Q3 2025), and $276000.0 (Q2 2025).